ENDV Endonovo Therapeutics, Inc.
Fundamentals / CIK 0001528172 / USDEndonovo Therapeutics, Inc. reported $256K in revenue and a net loss of $4.40M for the trailing twelve months ended September 30, 2023 (down 86.1% year over year), with a 96.2% gross margin and a -1023.2% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ENDV in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$256K -86.1% YoY
-
Operating Income TTM-$2.62M -1023.2% margin
-
Net Income TTM-$4.40M -1722.2% net margin
-
Diluted EPS TTM-$0.00 Split-adjusted
-
Free Cash Flow TTM-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2023$0 Total debt: $7.09M
Annual revenue and net income
10 fiscal years (2013 to 2022), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $135K | $73K | $166K | $310K | $83K | -- | -- | $4.3K | $24K | $23K |
| Cost of Revenue | $10.0K | $15K | $65K | $93K | $13K | -- | -- | $2.2K | $15K | $14K |
| Gross Profit | $125K | $58K | $100K | $217K | $70K | -- | -- | $2.1K | $8.7K | $8.9K |
| Research & Development | -- | $0 | $3.3K | $153K | $274K | $115K | $0 | -- | -- | -- |
| Total Operating Expenses | $3.39M | $2.28M | $3.01M | $4.03M | $4.23M | $4.60M | $5.41M | $2.57M | $2.20M | $2.44M |
| Operating Income | -$3.26M | -$2.23M | -$2.91M | -$3.81M | -$4.16M | -$4.60M | -$5.41M | -$2.56M | -$2.19M | -$2.43M |
| EBITDA | -$2.62M | -$1.58M | -$2.26M | -$3.16M | -$3.51M | -$4.59M | -$5.40M | -$2.55M | -$2.18M | -$2.42M |
| Interest Expense | -- | $942K | $2.08M | $17K | -- | -- | -- | -- | -- | -- |
| Income Before Tax | -$18.47M | -$3.10M | -$396K | -$17.31M | -$6.44M | -$10.81M | -$5.32M | -$6.77M | -$959K | -$2.89M |
| Income Tax Expense | -- | -- | -- | -- | -- | -- | -- | $0 | $0 | $532 |
| Net Income | -$18.47M | -$3.10M | -$396K | -$17.31M | -$6.44M | -$10.81M | -$5.32M | -$6.77M | -$959K | -$2.89M |
| Basic EPS | -$0.13 | -$0.05 | -$0.03 | -$24.83 | -$17.76 | -$0.04 | -$0.05 | -$0.07 | -$0.03 | -$3.96 |
| Diluted EPS | -- | -$0.05 | -$0.03 | -$24.83 | -$17.76 | -$0.04 | -$0.05 | -$0.07 | -$0.03 | -$3.96 |
| Basic Shares Outstanding | 139.2M | 59.8M | 12.2M | 697.3K | 362.5K | 242.1M | 117.4M | 96.8M | 30.3M | 730.5K |
| Diluted Shares Outstanding | -- | 59.8M | 12.2M | 697.3K | 362.5K | 242.1M | 117.4M | 96.8M | 30.3M | 730.5K |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.5K | $45K | $88K | $121K | $11K | $650 | $2.3K | $316 |
| Cost of Revenue | $827 | $0 | $4.0K | $4.9K | $4.0K | $383 | $714 | $8.9K |
| Gross Profit | $693 | $45K | $84K | $117K | $6.9K | $267 | $1.6K | -$8.5K |
| Research & Development | -- | -- | -- | -- | -- | -- | -- | $0 |
| Total Operating Expenses | $473K | $1.18M | $613K | $600K | $504K | $1.80M | $487K | $365K |
| Operating Income | -$473K | -$1.13M | -$529K | -$483K | -$497K | -$1.80M | -$486K | -$374K |
| EBITDA | -- | -- | -- | -$321K | -$335K | -$1.64M | -$324K | -$212K |
| Income Before Tax | -$766K | $2.06M | $7.23M | -$12.93M | -$603K | -$2.53M | -$2.41M | $2.40M |
| Net Income | -$766K | $2.06M | $7.23M | -$12.93M | -$603K | -$2.53M | -$2.41M | $2.40M |
| Basic EPS | -$0.00 | $0.00 | $0.03 | -- | $0.00 | -$0.02 | -$0.03 | -- |
| Diluted EPS | $0.00 | -$0.01 | $0.00 | -- | $0.00 | -$0.02 | -$0.03 | -- |
| Basic Shares Outstanding | 298.4M | 276.3M | 251.4M | -- | 153.6M | 134.4M | 79.0M | -- |
| Diluted Shares Outstanding | 1.35B | 1.35B | 1.74B | -- | 153.6M | 134.4M | 79.0M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $98 | $86K | $13K | $19K | $379K | $90K | $56K | $41K | $988 | $3.3K |
| Cash & Short-Term Investments | $98 | $86K | $13K | $19K | $379K | $90K | $56K | $41K | $988 | $3.3K |
| Accounts Receivable, Net | -- | $944 | $942 | $23K | $3.3K | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- | -- | -- | $336K | $2.0K | -- |
| Total Current Assets | $16K | $95K | $46K | $63K | $382K | $111K | $303K | $378K | $3.0K | $3.3K |
| Property, Plant & Equipment, Net | -- | -- | $1.6K | $5.9K | $6.7K | $1.1K | $16K | $32K | $43K | $58K |
| Goodwill | -- | -- | -- | -- | -- | -- | -- | -- | -- | $198K |
| Intangible Assets | $1.27M | $1.91M | $2.56M | $3.21M | $3.85M | $4.50M | -- | -- | -- | $12K |
| Total Non-Current Assets | $1.27M | $1.91M | $2.56M | $3.21M | $3.86M | $4.50M | $16K | $32K | $43K | $70K |
| Total Assets | $1.28M | $2.01M | $2.61M | $3.27M | $4.24M | $4.61M | $319K | $409K | $46K | $74K |
| Accounts Payable | $884K | $658K | $701K | $599K | $157K | $144K | -- | -- | -- | -- |
| Short-Term Debt | -- | -- | -- | -- | -- | $4.2K | $12K | $12K | $12K | -- |
| Total Current Liabilities | $33.38M | $17.70M | $16.83M | $23.62M | $15.48M | $13.41M | $8.72M | $9.49M | $4.55M | $4.01M |
| Long-Term Debt | $7.15M | $7.26M | $6.84M | $6.87M | $8.16M | $7.35M | $3.18M | $17K | $1.56M | -- |
| Other Non-Current Liabilities | $80K | $80K | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Non-Current Liabilities | $80K | $80K | $155K | $155K | $155K | $753K | $159K | $199K | $184K | $197K |
| Total Liabilities | $33.46M | $17.78M | $16.98M | $23.78M | $15.63M | $14.16M | $8.88M | $9.69M | $4.74M | $4.21M |
| Total Debt (incl. Leases) | $7.15M | $7.26M | $6.84M | $6.87M | $8.16M | $7.36M | $3.19M | $29K | $1.57M | -- |
| Common Stock | $21K | $7.4K | $2.5K | $118 | $43 | $32K | $13K | $10K | $8.1K | $832 |
| Retained Earnings | -$75.12M | -$56.44M | -$53.34M | -$52.93M | -$35.62M | -$29.18M | -$18.37M | -$13.06M | -$6.29M | -$5.33M |
| Total Stockholders' Equity | -$32.18M | -$15.77M | -$14.37M | -$20.50M | -$11.39M | -$9.55M | -$8.56M | -$9.28M | -$4.69M | -$4.13M |
| Total Equity | -$32.18M | -$15.77M | -$14.37M | -$20.50M | -$11.39M | -$9.55M | -$8.56M | -$9.28M | -$4.69M | -$4.13M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $0 | $33K | $11K | $98 | $23K | $0 | $60K | $86K |
| Cash & Short-Term Investments | $0 | $33K | $11K | $98 | $23K | $0 | $60K | $86K |
| Accounts Receivable, Net | -- | -- | $3.1K | -- | $944 | $945 | $945 | $944 |
| Total Current Assets | $36K | $73K | $95K | $16K | $24K | $5.9K | $64K | $95K |
| Intangible Assets | $780K | $942K | $1.10M | $1.27M | $1.43M | $1.59M | $1.75M | $1.91M |
| Total Non-Current Assets | $780K | $942K | $1.10M | $1.27M | $1.43M | $1.59M | $1.75M | $1.91M |
| Total Assets | $816K | $1.01M | $1.20M | $1.28M | $1.45M | $1.59M | $1.82M | $2.01M |
| Accounts Payable | -- | -- | -- | $884K | $866K | $786K | $704K | $658K |
| Total Current Liabilities | $23.70M | $23.14M | $25.49M | $33.38M | $20.98M | $20.68M | $19.77M | $17.70M |
| Long-Term Debt | $7.09M | $7.05M | $6.90M | $7.15M | $7.27M | $7.41M | $7.35M | $7.26M |
| Other Non-Current Liabilities | -- | -- | -- | $80K | -- | -- | -- | $80K |
| Total Non-Current Liabilities | $80K | $80K | $80K | $80K | $80K | $80K | $80K | $80K |
| Total Liabilities | $23.78M | $23.22M | $25.57M | $33.46M | $21.06M | $20.75M | $19.85M | $17.78M |
| Total Debt (incl. Leases) | $7.09M | $7.05M | $6.90M | $7.15M | $7.27M | $7.41M | $7.35M | $7.26M |
| Common Stock | $28K | $28K | $27K | $21K | $16K | $15K | $8.1K | $7.4K |
| Retained Earnings | -$66.63M | -$65.86M | -$67.93M | -$75.12M | -$61.99M | -$61.38M | -$58.86M | -$56.44M |
| Total Stockholders' Equity | -$22.96M | -$22.41M | -$24.37M | -$32.18M | -$19.61M | -$19.16M | -$18.04M | -$15.77M |
| Total Equity | -$22.96M | -$22.41M | -$24.37M | -$32.18M | -$19.61M | -$19.16M | -$18.04M | -$15.77M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$18.47M | -$3.10M | -$396K | -$17.31M | -$6.44M | -$10.81M | -$5.32M | -$6.77M | -$959K | -$2.89M |
| Depreciation & Amortization | $647K | $648K | $651K | $650K | $650K | $15K | $16K | $15K | $16K | $12K |
| Stock-Based Compensation | $45K | $0 | $57K | $31K | -- | -- | -- | -- | -- | -- |
| Change in Receivables | -- | -$2 | $22K | -$19K | -$3.3K | -- | -- | -- | -- | -$300 |
| Change in Payables | -- | -$42K | $94K | $442K | $63K | -$112K | -- | -- | -- | -- |
| Operating Cash Flow | -$679K | -$987K | -$742K | -$2.54M | -$2.88M | -$2.99M | -$2.46M | -$1.02M | -$909K | -$257K |
| Capital Expenditure | -- | -- | -- | -$2.6K | -$9.0K | -- | -- | -$3.8K | $0 | -- |
| Free Cash Flow | -- | -- | -- | -$2.54M | -$2.89M | -- | -- | -$1.02M | -$909K | -- |
| Acquisitions, Net | -- | -- | -- | -- | -- | -- | -- | -- | -- | $4.1K |
| Investing Cash Flow | -- | -- | -- | -$2.6K | -$9.0K | -$3.00M | -- | -$3.8K | $0 | $4.1K |
| Common Stock Issued | $142K | $126K | $100K | $168K | $85K | $1.29M | $1.24M | $139K | $0 | -- |
| Financing Cash Flow | $593K | $1.06M | $736K | $2.18M | $3.18M | $6.02M | $2.48M | $1.06M | $907K | $256K |
| Net Change in Cash | -$86K | $73K | -$5.5K | -$360K | $289K | $35K | $14K | $40K | -$2.3K | $2.5K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$766K | $2.06M | $7.23M | -$12.93M | -$603K | -$2.53M | -$2.41M | $2.40M |
| Depreciation & Amortization | -- | -- | -- | $162K | $162K | $162K | $162K | $162K |
| Stock-Based Compensation | $0 | $3.4K | $2.6K | -- | -- | -- | -- | -$61K |
| Change in Receivables | -- | -- | -$3.1K | -- | -- | -- | -- | $6.1K |
| Change in Payables | -- | -- | -- | -- | -- | -- | $46K | -$95K |
| Operating Cash Flow | -$65K | -$166K | -$173K | -$226K | -$124K | -$206K | -$123K | -$391K |
| Common Stock Issued | $3.8K | $46K | $207K | -- | -- | -- | -- | $0 |
| Financing Cash Flow | $33K | $188K | $184K | $202K | $147K | $146K | $97K | $472K |
| Net Change in Cash | -$33K | $22K | $11K | -$23K | $23K | -$60K | -$26K | $80K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 92.6% | 79.5% | 60.6% | 69.9% | 84.5% | -- | -- | 49.3% | 36.0% | 38.9% |
| Operating Margin | -2411.7% | -3045.7% | -1756.5% | -1228.1% | -4995.3% | -- | -- | -60132.7% | -9057.6% | -10607.6% |
| Net Profit Margin | -13649.2% | -4247.2% | -238.6% | -5582.4% | -7729.5% | -- | -- | -158633.9% | -3966.2% | -12634.5% |
| Return on Assets (ROA) | -1441.9% | -154.7% | -15.2% | -528.7% | -151.7% | -234.4% | -1668.0% | -1652.7% | -2104.7% | -3930.8% |
| Current Ratio | 0.00x | 0.01x | 0.00x | 0.00x | 0.02x | 0.01x | 0.03x | 0.04x | 0.00x | 0.00x |
| Quick Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.02x | 0.01x | 0.01x | 0.00x | 0.00x | 0.00x |
| Revenue Growth (YoY) | +85.2% | -55.9% | -46.5% | +272.5% | -- | -- | -- | -82.4% | +5.7% | -- |
| Gross Profit Growth (YoY) | +115.7% | -42.1% | -53.7% | +208.2% | -- | -- | -- | -75.8% | -2.2% | -- |
| 5Y Revenue / Share Growth | -- | -- | +30718.2% | +55588.8% | +632.9% | -- | -- | -99.6% | -- | -- |
| 10Y Revenue / Share Growth | -- | -87.8% | +20.2% | -- | -- | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 96.2% | 95.1% | 94.0% | 92.6% | 1.6% | -18.3% | 67.6% | 79.5% |
| Operating Margin | -1023.2% | -995.8% | -1499.4% | -2411.7% | -22206.4% | -30354.8% | -5217.0% | -3045.7% |
| Net Profit Margin | -1722.2% | -1599.5% | -4003.0% | -13649.2% | -22145.1% | -36842.6% | -6975.9% | -4247.2% |
| Return on Assets (ROA) | -539.9% | -417.9% | -736.6% | -1441.9% | -216.8% | -255.0% | -156.3% | -154.7% |
| Current Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x |
| Quick Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Revenue Growth (YoY) | -86.1% | +6853.8% | +3736.1% | +38337.7% | +40.7% | -97.9% | -93.4% | -97.3% |
| Gross Profit Growth (YoY) | -90.0% | +16828.8% | +5228.1% | -- | +47.9% | -99.1% | -95.1% | -- |
| Net Income Growth (YoY) | -- | -- | -- | -639.7% | -- | -- | -- | -- |